Invention Application
- Patent Title: Thiophene derivatives for the treatment of disorders caused by IgE
-
Application No.: US16973701Application Date: 2019-06-20
-
Publication No.: US20220332709A1Publication Date: 2022-10-20
- Inventor: Pfrafulkumar Tulshibhai Chovatia , Rickki Lee Connelly , Richard Jeremy Franklin , Gregory William Haslett , Alistair James Henry , James Madden , Judi Charlotte Neuss , Timothy John Norman , Oliver Philps , William Ross Pitt , Konstantinos Rampalakos , Matthew Duncan Selby , Suganthan Selvaratnam , Giancarlo Trani , Zhaoning Zhu
- Applicant: UCB Biopharma SRL
- Applicant Address: BE Brussels
- Assignee: UCB Biopharma SRL
- Current Assignee: UCB Biopharma SRL
- Current Assignee Address: BE Brussels
- Priority: EP18179126.0 20180621
- International Application: PCT/EP2019/066414 WO 20190620
- Main IPC: C07D409/14
- IPC: C07D409/14 ; C07D495/04 ; C07D333/78 ; C07D333/50 ; C07D409/12 ; C07D413/12 ; C07D487/04 ; C07D417/12 ; C07D498/10 ; C07D409/04 ; C07D413/04 ; C07D409/06 ; C07D495/10
Abstract:
Thiophene derivatives of formula (I) and a pharmaceutically acceptable salt thereof are provided. These compounds have utility for the treatment or prevention of disorders caused by IgE, such as allergy, type 1 hypersensitivity or familiar sinus inflammation.
Public/Granted literature
- US12018021B2 Thiophene derivatives for the treatment of disorders caused by IgE Public/Granted day:2024-06-25
Information query
